Subsequent Events (Details) - Subsequent events $ / shares in Units, $ in Millions	Mar. 28, 2024 USD ($) $ / shares shares	Mar. 27, 2024 USD ($) employee $ / shares
Strategic Portfolio Reprioritization and Workforce Reduction
Reduction in headcount (number of employees) | employee		15
Reduction in headcount (percent of employees)		21.00%
Initial Gilead Private Placement
License Agreement and Issuance of Commons Stock
Purchase price (in dollars per share) | $ / shares	$ 1.97
Number of shares sold | shares	6,860,223
Aggregate purchase price (in dollars) | $	$ 13.5
March 2024 Private Placement
License Agreement and Issuance of Commons Stock
Purchase price (in dollars per share) | $ / shares	$ 0.64
Number of shares sold | shares	1,953,125
March 2024 Private Placement
Warrants issued (in shares) | shares	15,627,441
Purchase price, warrant (in dollars per share) | $ / shares	$ 0.6399
License Agreement | Gilead Sciences, Inc.
License Agreement and Issuance of Commons Stock
Upfront payment to be received | $		$ 43.5
Upfront cash payment to be received | $		30.0
Amount of initial payment to be received related to equity investment | $		$ 13.5
Purchase price (in dollars per share) | $ / shares		$ 1.97